News 11.01.18

New at Pivot Park – Sterk Schakelen

Sterk Schakelen is now a member of the Pivot Park Community.

Read more
News 13.12.17

New at Pivot Park – CheckMark Labrecruitment

Since December 1st Checkmark Labrecruitment is present at Pivot Park.

Read more
News 11.12.17

ImmunoPrecise to Acquire ModiQuest Research BV

IMMUNOPRECISE ANTIBODIES LTD. announces that it has signed a binding letter of intent with ModiQuest Research BV.

Read more
News 02.11.17

Anglo-Dutch research teams awarded Eurostars funding for a €1.1M project to develop a synthetic matrix for 3D organoid cell culture

Researchers at Maastricht University, Noviocell BV (based at Pivot Park) and Cell Guidance Systems Ltd are collaborating on an EU funded Eurostars project to develop fully-defined matrices for the 3D culture of organoids.

Read more
News 02.11.17

US FDA APPROVES ASTRAZENECA’S CALQUENCE® (acalabrutinib) FOR ADULT PATIENTS WITH PREVIOUSLY-TREATED MANTLE CELL LYMPHOMA

AstraZeneca and its hematology research and development center of excellence, Acerta Pharma, today announced that the US Food and Drug Administration (FDA) has granted accelerated approval to CALQUENCE® (acalabrutinib).

Read more
News 19.10.17

Novel synergistic combinations identified by unbiased high-throughput screening

A high-throughput screening approach to identify novel synergistic drug combinations has been launched by NTRC.

Read more
News 19.10.17

Mirjam Mol neemt afscheid van Pivot Park

Mirjam Mol-Arts neemt afscheid als directeur van Pivot Park en het Pivot Park Screening Centre.

Read more
News 17.10.17

New at Pivot Park – ChardonPharma

Chardon Pharma recently moved into their laboratory in Pivot Park's Chesbrough Building.

Read more
News 17.10.17

New at Pivot Park – NanoServe

NanoServe has opened the doors of its office and laboratory at Pivot Park.

Read more